BioNexus Gene Lab BGLC Cash Flow Statement (2018-2026)

NASDAQ BGLC
$1.21 +0.00 (+0.41%)
As of: Oct 20, 2026 · 12:59 PM EDT
Reported Financials

BioNexus Gene Lab Quarterly Cash Flow Statement

Periods 33 quarters
Latest Jun 2026

BioNexus Gene Lab reported cash from operations of -$0.42M and free cash flow of -$0.42M for the quarter ended Jun 2026, up 42.7% year over year. This cash flow statement covers 33 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
0.30M0.09M0.02M-0.14M-0.08M-0.16M0.07M-0.26M-2.61M-0.31M-0.10M0.01M1.35M0.35M0.62M0.62M0.71M1.04M0.54M0.29M
Depreciation and DepletionDep. & Depletion
0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.02M0.06M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M-0.01M
Depreciation & Amortization (CF)Dep. & Amort.
0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.02M0.06M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Share-based CompensationStock Comp.
-0.09M0.79M
Deferred Taxes
0.00M0.02M
Gains from Investment SecuritiesGains Investment
0.00M0.01M0.00M-0.06M-0.07M0.20M0.04M-0.18M0.36M-0.53M-0.04M0.11M-0.01M0.01M-0.06M-0.03M0.00M
Asset Writedowns and ImpairmentWritedown
0.01M0.04M
Other non-cash itemsOther Non-Cash
0.00M0.01M0.01M-0.01M-0.01M0.01M97.000.00M-0.01M0.16M-0.05M0.77M0.04M0.17M0.07M0.22M0.07M
Non-cash ItemsNon-Cash Items
0.04M-0.06M0.00M-0.09M-0.05M-1.01M-0.79M-0.04M-0.34M-1.46M-0.51M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.33M-0.20M-0.11M-0.34M-0.02M-0.15M-0.15M-0.11M0.12M-0.15M0.00M0.11M0.26M-0.21M-0.94M-0.24M-0.07M
Change in InventoryChange Inventory
0.22M-0.03M0.13M-0.14M-0.42M0.97M-0.08M0.27M-0.06M-0.29M0.06M-0.17M0.36M-452.00-0.21M0.04M-0.21M-0.33M-0.01M
Change in Account PayablesChange Payables
0.05M-0.39M-0.21M-0.43M-0.13M0.65M-0.43M0.32M-0.25M-0.02M0.06M-0.51M0.20M0.46M-0.32M0.20M-1.11M-0.16M0.19M0.02M
Change in TaxesChange Taxes
-0.04M0.02M-0.03M-0.03M-0.09M0.14M0.00M0.03M0.00M0.02M0.01M-0.06M0.09M
Change in Other Operating AssetsOther Assets Change
-0.31M0.85M-0.07M0.54M-0.34M-0.02M-0.15M1.16M0.11M-0.11M-0.15M-0.25M-0.25M
Change in Other Operating LiabilitiesOther Liabilities Change
0.00M0.10M-0.11M-0.01M0.00M-0.10M-0.01M-0.01M0.09M-0.01M-0.01M-0.01M0.01M0.05M-0.08M-0.01M-0.01M-0.01M-0.01M-0.02M
Other Working Capital ChangesOther WC Changes
0.30M-0.74M-0.04M-0.01M0.00M-0.63M0.32M0.00M0.25M-1.17M-0.12M0.10M0.17M0.05M-0.08M-0.01M-0.01M-0.01M0.24M0.23M
Cash from OperationsCash from Ops.
0.32M0.48M-0.04M-0.20M0.31M0.48M-0.12M-0.02M-0.90M-0.78M-0.04M-0.67M-1.60M0.22M-0.82M-0.74M-1.24M0.96M-0.15M-0.42M
Investing Activities
Capital ExpendituresCapex
410.000.00M0.03M0.00M0.00M0.53M0.01M0.01M0.42M0.03M0.20M-0.17M0.20M0.00M0.01M0.02M0.01M977.00325.00250.00
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-410.000.00M-0.03M0.00M0.00M-0.53M-0.01M-0.01M-0.42M-0.03M-0.20M0.17M-0.20M0.00M-0.01M-0.02M-0.01M-977.00-325.00-250.00
Purchase of InvestmentsInvestments Purchased
0.06M0.08M0.17M0.23M-0.01M-0.40M0.01M-202.000.28M-0.29M0.22M0.01M95.00
Sale and Maturity of InvestmentsInvestments Sold
0.01M0.01M0.01M0.01M-0.02M0.12M0.03M-708.000.21M0.09M0.20M0.57M1.02M0.01M
Change in Acquisitions & DivestmentsChange Acquisitions
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-0.06M-0.08M-0.20M-0.22M0.02M-0.05M-0.01M0.00M-0.36M-1.43M0.00M0.06M-0.20M0.55M-0.02M-0.03M0.99M-0.01M-0.01M0.42M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.02M0.02M
Long-Term Debt RepaymentsLT Debt Repayment
-0.04M0.00M-0.07M
Non-Current Debt
0.04M0.00M0.07M0.02M-0.20M0.00M-860.00-525.000.03M-497.000.08M-0.01M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.04M0.00M0.07M0.02M-0.20M0.00M-860.00-525.000.03M-497.000.08M-0.01M
Change in Capital Stock
Common Stock IssuedStock Issued
0.00M-0.08M
Net Shares Issued and RepurchasedNet Shares Issued
0.00M-0.08M
Net Equity Issued and RepurchasedNet Equity Issued
0.00M-0.08M
Other financing activitiesOther financing
0.00M0.00M0.00M-0.49M0.03M0.17M-0.20M-860.00355.00-270.00
Cash from Financing ActivitiesCash from Financing
-0.01M0.00M0.11M0.00M0.00M0.00M0.00M5.75M0.53M0.03M0.18M-0.06M-0.14M-860.000.00M0.03M0.27M0.06M0.01M
Additional items
Exchange Rate EffectFX Effect
-0.03M0.02M-0.04M-0.20M-0.20M0.23M-0.02M-0.19M-0.10M0.05M-0.07M-0.04M0.57M-0.41M0.04M0.22M0.03M-0.09M0.01M-0.01M
Change in Cash
0.22M0.42M-0.28M-0.50M1.45M-0.67M-0.15M-0.21M4.39M-1.63M-0.08M-0.48M-1.30M0.22M-0.80M-0.55M-0.18M1.13M-0.09M-0.01M
Ending Cash Balance
1.70M2.12M1.84M1.34M1.46M2.12M1.97M1.76M6.15M4.52M4.44M3.96M2.67M2.89M2.09M1.54M1.36M2.49M2.40M2.39M
Free Cash FlowFCF
0.32M0.48M-0.07M-0.20M0.31M-0.05M-0.13M-0.04M-1.32M-0.81M-0.23M-0.50M-1.80M0.22M-0.83M-0.76M-1.24M0.96M-0.15M-0.42M
Net Cash FlowNCF
0.25M0.40M-0.23M-0.31M0.33M0.42M-0.12M-0.03M4.49M-1.68M-0.01M-0.43M-1.86M0.63M-0.84M-0.77M-0.21M1.22M-0.10M0.01M
Interest Paid
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-869.000.00M0.00M0.00M0.00M0.00M0.00M0.00M315.00269.00595.00
Income Taxes PaidTaxes Paid
-0.14M-0.13M-0.04M-0.03M0.20M-0.29M-0.01M-0.02M-0.02M-0.02M-0.01M-0.01M-0.01M-538.000.00M0.02M-0.03M-154.00

BioNexus Gene Lab Cash Flow Statement API

Pull BioNexus Gene Lab's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BGLC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY